Exogenous Chromophores for Laser Photosurgery (PDT)
After extensive research1, 2, over 10 years, and the treatment of thousands of patients, laser PDT surgery is here and for the future, The National Cancer Institute, USA, declares, with reason, that today, these are the priority cancers for PDT, primarily endobronchial cancer, early gastric cancer, and bladder cancer. This formal recommendation has not interfered with continued research and PDT for many other clinical types of cancer.
KeywordsEarly Gastric Cancer Thermal Sensor Turbid Medium Hyperthermia Treatment Photon Transmission
Unable to display preview. Download preview PDF.
- 1.L. Goldman, “Laser Cancer Research”, Springer Verlag Inc., New York (1966)Google Scholar
- 2.T. J. Dougherty, J. E. Kaufman, A. Goldfarb, K. R. Weishauft, and D. Boyle, “Photoradiation Therapy for the Treatment of Malignant Tumors Cancer Research”, 38:2628–2635 (1978)Google Scholar
- 3.G. Nath, personal communicationGoogle Scholar
- 5.N. Levine, personal communicationGoogle Scholar
- 6.L. Goldman, “Chromophores in Tissue for Laser Medicine and Surgery Lasers” in Medical Science, Bailliere and Tindall, London (1990)Google Scholar
- 8.S. Anderson-Engels, “Photodynamic therapy and simultaneous near infra-red light inducing hyperthermia in human cancer tumors”, ICALEO, San Diego, November (1987)Google Scholar
- 9.K. Svanberg, “Cancer Hyperthermia Cancer Res.” 46:3803 1986Google Scholar
- 10.E. Drexler, “Nanobiotechnology”, J. E. Dettling, O. E. Reports SPIE:51 1988Google Scholar
- 11.L. Goldman, R. O. Gregory, M. LaPlant “Preliminary Investigative Studies with PDT in Dermatologic and Plastic Surgery Lasers in Surgery and Medicine” 5:453–456 (1985)Google Scholar
- 12.P. Spinelli, Personal CommunicationGoogle Scholar
- 13.S. Potter, “Fluorescence Detection with background Subtraction for Localization of Tumors”, ICALEO, San Diego (1987)Google Scholar